Data as of Q4 2025 (Dec 31, 2025)

SIONNA THERAPEUTICS, INC.

(SION)

Financial Statements · SEC EDGAR XBRL

Net Income
-$75.3M
-22.0%
EPS
$-1.88
+88.2%
Op. Income
-$89.0M
-26.1%
FCF
-$66.7M
-26.2%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
$60.3M
$57.3M
$89.0M
$70.6M
-$89.0M
-$70.6M
$13.7M
$8.9M
$0
$0
-$75.3M
-$61.7M
$-1.88
$-15.99
$-1.88
$-15.99
40.0M
3.9M